We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
RJ Tesi MD is a founder and the CEO of INmune Bio since company formation in 2015. RJ Tesi has held many roles in public and private biotech companies on both the development and commercial sides of the business. Dr. Tesi has been on transaction teams for company financings for both private and public companies, has been active in licensing of therapeutic products, has led development programs for drugs in the immunotherapy space, has launched products into commercial markets and has set strategy at all levels of the business. Prior to joining industry, Dr. Tesi was an academic transplant surgeon.
This speaker's sessions: